News » Press Room » Press Archives

Press Archives

April 08, 2022

The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron. The trial aims to understand if different vaccine regimens – prototype and variant vaccines alone and in combinations – can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.

March 25, 2022

WASHINGTON (March 24, 2022) -

Dr. Robert Sterling Headshot
March 07, 2022

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) and the GW Medical Faculty Associates (GW MFA) are pleased to announce the appointment of Robert Sterling, MD, FAAOS, FAOA, as the new chair of GW’s Department of Orthopaedic Surgery. In this role, Sterling will lead the further development of the department’s clinical, educational, and academic missions.

Tim McCaffrey holding a slide
January 26, 2022

George Washington University researchers have developed a blood test that quickly detects if someone has COVID-19 and predicts how severely the immune system will react to the infection, according to a new study coming out today in PLOS One. The findings could one day lead to a powerful tool to help doctors determine the best treatment plan for people with COVID-19.

Rong Li Standing in his lab
November 03, 2021

George Washington University researchers have identified a key molecule in certain kinds of breast cancers that prevent immune cells from entering tumors and killing the cancer cells inside. The paper and its findings, published today in Nature, could pave the way toward a new treatment for certain kinds of aggressive breast cancer.

September 10, 2021

The George Washington University School of Medicine and Health Sciences researchers have been awarded a $3.6 million contract to genetically modify commensal organisms to produce antidotes for harmful biological and chemical agents, such as anthrax, Ebola, and even COVID-19.

July 27, 2021

The George Washington University (GW) School of Medicine and Health Sciences (SMHS) was recently awarded a T32 Ruth L. Kirschstein National Research Service Award institutional research training grant from the Health Resources and Services Administration (HRSA), an agency of the U.S. Department of Health and Human Services focused on health care for individuals who are geographically isolated and/or economically or medically vulnerable.